Mesenteric Artery Ischemia

Back

Background

Patients with mesenteric ischemia have a rare, potentially life-threatening disease and may present to the primary care or emergency medicine physician. Acute and chronic forms of mesenteric ischemia share many similarities and have many differences (see images below). This article discusses mesenteric artery ischemia in general. Acute Mesenteric Ischemia, Chronic Mesenteric Ischemia, Mesenteric Artery Thrombosis, and Mesenteric Venous Thrombosis discuss the specific types of mesenteric ischemia.


View Image

Angiogram of a patient with chronic mesenteric ischemia.


View Image

Radiograph showing bowel spasm, an early sign of ischemia.


View Image

Gas in the colon wall, typical of advanced ischemia.


View Image

Ischemia stricture.

First described by Antonio Hodgson in the latter part of the 15th century, the medical profession did not become interested in this condition until the middle of the 19th century. By the turn of this century, many review articles and texts were written describing the advances in the characterization and treatment of mesenteric ischemia.

In 1901, Schnitzler described a patient with a long history of postprandial pain who was found to have an atherosclerotic plaque with overlying thrombus of the superior mesenteric artery (SMA). Schnitzler concluded that if patients could develop pain of their lower extremities secondary to atherosclerosis, patients could also develop postprandial pain as a result of atherosclerosis of the mesenteric vessels. By the middle of the 20th century, Dunphy correctly hypothesized that mesenteric ischemia was a manifestation of visceral atherosclerosis.

History of the Procedure

In 1958, Shaw and Maynard described the first thromboendarterectomy of the SMA for the treatment of acute and chronic mesenteric ischemia. Several other surgical techniques have been used to revascularize obstructed mesenteric vessels, including reimplantation of the mesenteric vessels into the adjacent aorta, transaortic visceral thromboendarterectomy first described by Stoney and Wylie in 1972, and aortovisceral bypass with vein or prosthetic grafts.

Problem

While acute mesenteric ischemia is a surgical emergency, patients with chronic mesenteric ischemia typically present with a more benign process. The specific causes of mesenteric ischemia include the following:

Whatever the cause, the result is a decreased blood supply to the small and/or large bowel resulting in ischemia, bowel infarction, necrosis, sepsis, and, ultimately, death.

Epidemiology

Frequency

Mesenteric ischemia accounts for 0.1% of all hospital admissions. Risk factors for this disease include atherosclerosis, arrhythmias, hypovolemia, congestive heart failure, recent myocardial infarction (MI), valvular disease, advanced age, and intra-abdominal malignancy.[1, 2] Mesenteric artery stenosis is found in 17.5% of independent elderly adults.[3]

Etiology

Etiology can be divided into acute and chronic obstructive and nonobstructive causes.

Acute mesenteric arterial embolism usually occurs when emboli from the heart lodge in the mesenteric arteries. The sources of such emboli can be from blood stasis secondary to atrial fibrillation or from a mural thrombus after an MI.

Valvular lesions can also result in emboli to the mesenteric system. Rarely, an embolus may be composed of atherosclerotic debris that may be dislodged during arteriography or surgery, such as aortic aneurysm resection. Most emboli lodge in the SMA, just distal to the origin of the middle colic artery.

Thrombosis typically occurs at the artery origin, resulting in more structures affected by the occlusion. Embolization, unlike thrombosis, causes less ischemic disease and is associated with better survival. Mesenteric emboli account for 50% of all cases of mesenteric ischemia.

Nonocclusive mesenteric ischemia can occur without any arterial or venous abnormalities. Typically, patients have some degree of atherosclerosis of the mesenteric vessels and report symptoms when external forces such as intra-abdominal tumors compress the vessel or when they have poor perfusion secondary to congestive heart failure, MI, or hypovolemia. It is generally a syndrome of vasospasm and constriction that typically occurs in critically ill patients who are in low-flow states (eg, from septic shock, cardiac shock, burns, or hypovolemic shock).

Low-flow states cause peripheral vasodilation and shunting of the blood from the gut to the periphery. Even treatment of mesenteric insufficiency by revascularization can result in vasospasm and an ischemic episode. Cases of patients without atherosclerotic disease of their mesenteric arteries having ischemia have been reported, but this is rare and occurs in patients with profound hypovolemic shock.

Finally, digitalis has been found to cause vasoconstriction of arterial and venous smooth muscle cells in the mesenteric vasculature. Of patients with acute mesenteric ischemia, 20-30% have nonocclusive disease.

Chronic mesenteric ischemia can be the precursor to any of the above conditions. When the arterial lumen is narrowed secondary to atherosclerosis, any increase in demand of the gut (eg, eating) or a decrease in supply (eg, hypovolemia) can result in severe abdominal pain and possibly infarction. The risk factors for atherosclerosis are therefore pertinent to the development of chronic mesenteric ischemia.

Pathophysiology

Acute insufficiency of the splanchnic blood flow can result from an arterial or venous occlusive process or a nonocclusive process such as vasospasm. The splanchnic blood flow normally ranges from 10-40% of the cardiac output depending on the state of the patient. This wide variation in flow through the mesenteric system is caused by local and regional control mechanisms. Adenosine, a metabolic byproduct of ischemia, causes dilation of the splanchnic vessels, as does nitric oxide. The sympathetic system antagonizes these vasodilatory effects and causes redirection of the blood from the gut to the more vital brain and heart during times of stress. Activation of the renin-angiotensin pathway is also known to cause vasoconstriction of the splanchnic bed. During times of hypovolemia, a patient may experience nonobstructive mesenteric ischemia because of the low-flow state. The mechanism by which a patient experiences pain because of the ischemia is poorly understood.

The consequences of vascular occlusion depend on the vessels involved. A patient with chronic mesenteric ischemia with atrial fibrillation who has an embolism to a branch of the SMA may experience mild or no symptoms because of adequate collateral flow. The patient with acute thrombosis loses perfusion from the origin of the SMA, resulting in a greater amount of dead bowel. Tissue injury can result from one of 2 mechanisms: (1) ischemic injury to the bowel or (2) reperfusion injury.

Within 4 hours after ischemia begins, the mucosal villi become necrotic. As early as 6 hours, full-thickness infarction can be observed (see the first 2 images below). Submucosal hemorrhage and edema in the colon produce a characteristic thumbprinting that is depicted in the third image below. If left untreated, patients can hemorrhage into their bowel, experience perforation, and, ultimately, become septic and die.


View Image

Pathologic findings 2 hours after bowel ischemia starts.


View Image

Microscopic findings 24 hours after the start of ischemia.


View Image

Thumbprinting of the bowel, a characteristic of mesenteric artery ischemia.

Reperfusion injury occurs when ischemic bowel regains its blood flow. The result is a release of oxygen free radicals by leukocytes. Other factors, such as phospholipase A2, up-regulate prostaglandins and leukotrienes, which causes more injury.

Presentation

Patients with mesenteric ischemia have a very typical presentation. However, the diagnosis may be overlooked because of the vague nature of the patients' symptoms.[4] Depending on the type of mesenteric ischemia, patients may present with a variety of signs and symptoms. Patients may present with a history of postprandial pain, typically starting 20-30 minutes after their last meal, that may last up to 60-90 minutes. Because of this, they develop food fear and experience subsequent weight loss. Patients may be severely malnourished upon presentation.

Some patients may present with an acute onset of severe abdominal pain without a history of previous postprandial pain. These patients may report blood in their stool as their bowel begins to die. The classic patient with chronic mesenteric ischemia may provide a history of postprandial pain between 10 minutes and 3 hours after a meal. The pain can become so severe that the patient may develop a fear of eating and report recent weight loss. Patients may report diarrhea or constipation, and occult testing of stool may return positive results because of the sloughing of dead ischemic bowel.

Patients with acute mesenteric ischemia provide a history of sudden onset of symptoms. Further exploration may reveal a history similar to persons with chronic ischemia. Review of the past medical history may reveal other manifestations of atherosclerotic disease such as MI, stroke, or peripheral vascular disease.

Upon physical examination, the patient is thin and writhing in pain. Palpation of the abdomen reveals no peritoneal signs (pain out of proportion to examination), and auscultation of the abdomen may reveal a bruit.

Indications

Once a diagnosis of acute mesenteric ischemia is confirmed, the patient should undergo surgery because of the risk of weight loss, pain, bowel infarction, and possible death. If chronic mesenteric ischemia is diagnosed, patients should be evaluated for cardiopulmonary and renal disease before surgery is considered.

Relevant Anatomy

Mastery of the anatomy of the mesenteric vessels is essential to understanding and treating patients with mesenteric artery ischemia. Unfortunately, the endless array of vascular variations can make this difficult.

Because of the multiple areas of potential collateral flow in the mesenteric system, at least 2 of the 3 vessels must be occluded to produce chronic ischemia.

Contraindications

Laboratory Studies

Imaging Studies

Other Tests

Medical Therapy

Surgical Therapy

In cases of acute mesenteric ischemia, the surgeon should decide the location of viable versus nonviable bowel during surgery. Laparotomy reveals that the entire small bowel and proximal colon are affected in patients with SMA thrombosis, reflecting the proximal nature of this disorder. In contrast, patients with SMA embolization have sparing of their proximal jejunum, reflecting the more distal obstruction.

In patients with extensive bowel involvement, make every effort to retain every centimeter of viable bowel. If determining bowel viability is difficult, a second look may be required 24-48 hours later. Patients with emboli are treated with an embolectomy by exposing the SMA below the mesocolon distal to the middle colic artery. A longitudinal arteriotomy is made, and a Fogarty catheter is passed distal to the embolus, is inflated, and is used to extract the embolus. If closure of the arteriotomy is difficult, a patch graft may be used or the patient may require an endarterectomy. Other methods of reperfusion involving prosthetic bypass grafting or autogenous vein grafting have also been performed, and the reader is directed to a surgical technique manual for further discussion.

Kougias et al compared the effectiveness of balloon angioplasty and/or endovascular stenting (48 patients, 58 vessels) with that of open revascularization (96 patients, 157 vessels) in the treatment of chronic mesenteric ischemia.[5] The investigators found that members of the endovascular group had a shorter hospital stay (3 days) than did patients in the open revascularization group (12 days, P < 0.03) and that the 30-day mortality rate, frequency of inhospital complications, and 3-year cumulative survival rate were the same for both groups.

Three years after the procedures, however, cumulative freedom from recurrent symptoms was found in a higher percentage of open revascularization patients than in members of the endovascular group (66% vs 27%, P < 0.02). The authors suggested that this was because the percentage of patients who underwent a 2-vessel procedure rather than a 1-vessel intervention was higher in the open group than in the endovascular one.

Another study compared the outcomes of patients with chronic mesenteric ischemia who were treated with open mesenteric revascularization before (pre-endo group) and after (post-endo group) the preferential use of endovascular revascularization. The results found that patients treated post-endo presented with higher rates of hypertension, hyperlipidemia, cardiac interventions, and dysrhythmias; higher comorbidity scores; and more extensive mesenteric artery disease. However, similar outcomes for operative mortality, morbidity, length of stay, and immediate symptom improvement were noted in both the pre-endo and post-endo groups. Primary and secondary patency rates and recurrence-free survival rates were 82%, 86%, and 84% in the pre-endo group and 81%, 82%, and 76% in the post-endo group, respectively, at 5 years.[6]

Oderich et al studied 156 patients treated for mesenteric artery complications during angioplasty and stent replacement for chronic mesenteric ischemia. They concluded that complications occurred in 7% of patients, who experienced higher mortality, higher morbidity, and longer hospital stays.[7]

Preoperative Details

Intraoperative Details

Postoperative Details

Follow-up

Complications

Because of the high prevalence of atherosclerosis, one of the most common complications involves MI. Prevent postoperative MI by identifying correctable coronary artery disease before the patient enters the operating room, if possible. During the perioperative period, use a Swan-Ganz catheter to monitor fluid and cardiac function. Finally, when cross-clamping the supraceliac aorta, notify the anesthesiologist, who can use myocardial protective maneuvers and afterload reduction to maximize cardiac output.

Acute renal failure in the immediate postoperative period can be prevented by keeping the patient well hydrated and administering mannitol before the aorta is cross-clamped.

Other possible complications include bleeding, infection, bowel infarction, prolonged ileus, and graft infection.

Outcome and Prognosis

Because of the delay in diagnosis, mesenteric artery ischemia is typically a lethal disease, with a mortality rate of 45-65%. When more than half the bowel is removed, mortality rates of up to 80% have been reported. A review of 45 studies demonstrated that the prognosis for patients with acute mesenteric ischemia differs when one looks at the etiology. Mortality rates are highest for patients with arterial thrombosis (70-87%), followed by nonocclusive mesenteric ischemia (70-80%), arterial embolism (66-71%), and venous thrombosis (44%). Mortality rates have been improving over the last 4 decades.

Future and Controversies

Over the past 20 years, diagnosis and treatment of mesenteric ischemia has advanced only minimally.

Author

Brian James Daley, MD, MBA, FACS, FCCP, CNSC, Professor and Program Director, Department of Surgery, Chief, Division of Trauma and Critical Care, University of Tennessee Health Science Center College of Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Chandler Long, MD, Resident Physician, Department of Surgery, University of Tennessee Medical Center-Knoxville

Disclosure: Nothing to disclose.

Specialty Editors

Burt Cagir, MD, FACS, Assistant Professor of Surgery, State University of New York Upstate Medical University; Consulting Staff, Director of Surgical Research, Robert Packer Hospital; Associate Program Director, Department of Surgery, Guthrie Clinic

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Michael A Grosso, MD, Consulting Staff, Department of Cardiothoracic Surgery, St Francis Hospital

Disclosure: Nothing to disclose.

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy

Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, DSc, MA, Vice Chair and Professor, Department of Surgery, Section of Gastrointestinal Medicine, and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director, Surgical Research, Department of Surgery, Yale-New Haven Hospital

Disclosure: AMGEN Royalty Consulting; Ardelyx Ownership interest Board membership

Additional Contributors

Yale D Podnos, MD, MPH Consulting Surgeon, Department of Surgery, City of Hope National Medical Center

Disclosure: Nothing to disclose.

Deron J Tessier, MD Staff Surgeon, Kaiser Permanente Medical Center, Fontana, CA

Deron J Tessier, MD is a member of the following medical societies: American College of Surgeons and American Medical Association

Disclosure: Nothing to disclose.

Russell A Williams, MBBS Program Director, Professor, Department of Surgery, University of California Medical Center at Irvine

Disclosure: Nothing to disclose.

References

  1. Cappell MS. Intestinal (mesenteric) vasculopathy. II. Ischemic colitis and chronic mesenteric ischemia. Gastroenterol Clin North Am. Dec 1998;27(4):827-60, vi. [View Abstract]
  2. Ha C, Magowan S, Accortt NA, et al. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. Jun 2009;104(6):1445-51. [View Abstract]
  3. Cardin F, Fratta S, Perissinotto E, Casarrubea G, Inelmen EM, Terranova C, et al. Clinical correlation of mesenteric vascular disease in older patients. Aging Clin Exp Res. Jun 2012;24(3 Suppl):43-6. [View Abstract]
  4. Cappell MS. Intestinal (mesenteric) vasculopathy. I. Acute superior mesenteric arteriopathy and venopathy. Gastroenterol Clin North Am. Dec 1998;27(4):783-825, vi. [View Abstract]
  5. Kougias P, Huynh TT, Lin PH. Clinical outcomes of mesenteric artery stenting versus surgical revascularization in chronic mesenteric ischemia. Int Angiol. Apr 2009;28(2):132-7. [View Abstract]
  6. Ryer EJ, Oderich GS, Bower TC, et al. Differences in anatomy and outcomes in patients treated with open mesenteric revascularization before and after the endovascular era. J Vasc Surg. Jun 2011;53(6):1611-1618.e2. [View Abstract]
  7. Oderich GS, Tallarita T, Gloviczki P, Duncan AA, Kalra M, Misra S, et al. Mesenteric artery complications during angioplasty and stent placement for atherosclerotic chronic mesenteric ischemia. J Vasc Surg. Apr 2012;55(4):1063-71. [View Abstract]
  8. Kim MY, Suh CH, Kim ST, et al. Magnetic resonance imaging of bowel ischemia induced by ligation of superior mesenteric artery and vein in a cat model. J Comput Assist Tomogr. Mar-Apr 2004;28(2):187-92. [View Abstract]
  9. Aksu C, Demirpolat G, Oran I, et al. Stent implantation in chronic mesenteric ischemia. Acta Radiol. Jul 2009;50(6):610-6. [View Abstract]
  10. Loffroy R, Steinmetz E, Guiu B, et al. Role for endovascular therapy in chronic mesenteric ischemia. Can J Gastroenterol. May 2009;23(5):365-73. [View Abstract]
  11. Penugonda N, Gardi D, Schreiber T. Percutaneous intervention of superior mesenteric artery stenosis in elderly patients. Clin Cardiol. May 2009;32(5):232-5. [View Abstract]
  12. Mitchell EL, Chang EY, Landry GJ, et al. Duplex criteria for native superior mesenteric artery stenosis overestimate stenosis in stented superior mesenteric arteries. J Vasc Surg. Feb 20 2009;[View Abstract]
  13. Sivamurthy N, Rhodes JM, Lee D. Endovascular versus open mesenteric revascularization: immediate benefits do not equate with short-term functional outcomes. J Am Coll Surg. 2006;202(6):859-67.
  14. Schoots IG, Levi MM, Reekers JA. Thrombolytic therapy for acute superior mesenteric artery occlusion. J Vasc Interv Radiol. Mar 2005;16(3):317-29. [View Abstract]
  15. Bingol H, Zeybek N, Cingoz F, et al. Surgical therapy for acute superior mesenteric artery embolism. Am J Surg. Jul 2004;188(1):68-70. [View Abstract]
  16. Cooperman M, Martin EW Jr, Carey LC. Evaluation of ischemic intestine by Doppler ultrasound. Am J Surg. Jan 1980;139(1):73-7. [View Abstract]
  17. Eker A, Malzac B, Teboul J, Jourdan J. Mesenteric ischemia after coronary artery bypass grafting: should local continuous intra-arterial perfusion with papaverine be regarded as a treatment?. Eur J Cardiothorac Surg. Feb 1999;15(2):218-20. [View Abstract]
  18. Hansen KJ, Wilson DB, Craven TE, et al. Mesenteric artery disease in the elderly. J Vasc Surg. Jul 2004;40(1):45-52. [View Abstract]
  19. Kihara TK, Blebea J, Anderson KM, et al. Risk factors and outcomes following revascularization for chronic mesenteric ischemia. Ann Vasc Surg. Jan 1999;13(1):37-44. [View Abstract]
  20. Mamode N, Pickford I, Leiberman P. Failure to improve outcome in acute mesenteric ischaemia: seven-year review. Eur J Surg. Mar 1999;165(3):203-8. [View Abstract]
  21. Milner R, Woo EY, Carpenter JP. Superior mesenteric artery angioplasty and stenting via a retrograde approach in a patient with bowel ischemia--a case report. Vasc Endovascular Surg. Jan-Feb 2004;38(1):89-91. [View Abstract]
  22. Nyman U, Ivancev K, Lindh M, Uher P. Endovascular treatment of chronic mesenteric ischemia: report of five cases. Cardiovasc Intervent Radiol. Jul-Aug 1998;21(4):305-13. [View Abstract]
  23. Redaelli CA, Schilling MK, Buchler MW. Intraoperative laser Doppler flowmetry: a predictor of ischemic injury in acute mesenteric infarction. Dig Surg. 1998;15(1):55-9. [View Abstract]
  24. Schoots IG, Koffeman GI, Legemate DA, et al. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg. Jan 2004;91(1):17-27. [View Abstract]
  25. Seidel SA, Bradshaw LA, Ladipo JK, et al. Noninvasive detection of ischemic bowel. J Vasc Surg. Aug 1999;30(2):309-19. [View Abstract]
  26. Yasuhara H. Acute mesenteric ischemia: the challenge of gastroenterology. Surg Today. 2005;35(3):185-95. [View Abstract]

Angiogram of a patient with chronic mesenteric ischemia.

Radiograph showing bowel spasm, an early sign of ischemia.

Gas in the colon wall, typical of advanced ischemia.

Ischemia stricture.

Pathologic findings 2 hours after bowel ischemia starts.

Microscopic findings 24 hours after the start of ischemia.

Thumbprinting of the bowel, a characteristic of mesenteric artery ischemia.

Gross specimen showing hemorrhagic dead bowel.

Angiogram of a patient with chronic mesenteric ischemia.

Aortogram showing narrowing of the superior mesenteric artery.

Radiograph showing bowel spasm, an early sign of ischemia.

Gas in the colon wall, typical of advanced ischemia.

Ischemia stricture.

Meandering artery, a sign of chronic mesenteric artery ischemia.

Thumbprinting of the bowel, a characteristic of mesenteric artery ischemia.

Pathologic findings 2 hours after bowel ischemia starts.

Microscopic findings 24 hours after the start of ischemia.

Gross specimen showing hemorrhagic dead bowel.